Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wan‐jie Niu"'
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Numerous vancomycin population pharmacokinetic models in neonates have been published; however, their predictive performances remain unknown. This study aims to evaluate their external predictability and explore the factors that might aff
Externí odkaz:
https://doaj.org/article/aa4f4e795fde45a5901f06aa698a1926
Autor:
Zi‐ran Li, Rui‐dong Li, Wan‐jie Niu, Xin‐yi Zheng, Zheng‐xin Wang, Ming‐kang Zhong, Xiao‐yan Qiu
Publikováno v:
The Journal of Clinical Pharmacology. 63:314-325
This study aimed to develop and evaluate a population pharmacokinetic (PPK) combined machine learning approach to predict tacrolimus trough concentrations for Chinese adult liver transplant recipients in the early post-transplant period. Tacrolimus t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4511cdbac9f15934ed99671208223a0e
https://doi.org/10.1002/jcph.2156
https://doi.org/10.1002/jcph.2156
Autor:
Zi-ran Li, Cong-huan Shen, Rui-dong Li, Bei Wang, Juan Li, Wan-jie Niu, Li-jun Zhang, Ming-kang Zhong, Zheng-xin Wang, Xiao-yan Qiu
Publikováno v:
European Journal of Pharmaceutical Sciences. 184:106405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8071ca844fbb1168537671f1573a2798
https://doi.org/10.1016/j.ejps.2023.106405
https://doi.org/10.1016/j.ejps.2023.106405
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 167
Background Efavirenz is a vital component used to treat HIV-1 infection. Nevertheless, it shows large between-subject variability, which affects both its therapeutic response and adverse effects. Objective To investigate the impact of gene polymorphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3555c3f089338c721ad6fb6e6adbb6ba
https://pubmed.ncbi.nlm.nih.gov/34474119
https://pubmed.ncbi.nlm.nih.gov/34474119
Autor:
Xiaoqiang Xiang, Meng-wan Zhang, Wan-jie Niu, Weimin Cai, Size Li, Shasha Jin, Xi-ying Lin, Zheng Jiao
Publikováno v:
British Journal of Clinical Pharmacology
BACKGROUND AND OBJECTIVE: Hypertension is a common comorbidity of patients with COVID-19, SARS or HIV infection. Such patients are often concomitantly treated with antiviral and antihypertensive agents, including ritonavir and nifedipine. Since riton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce78bab96aff60c34c7e3366b445c621
Autor:
Shasha Jin, Zheng Jiao, Wan-jie Niu, Size Li, Xiaoqiang Xiang, Mingkang Zhong, Weimin Cai, Meng-wan Zhang, Xi-ying Lin
Background and ObjectiveHypertension is a common comorbidity of patients with COVID-19, SARS or HIV infection. Those patients are often treated with commonly used antiviral and antihypertensive agents concomitantly, such as ritonavir-containing regim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe980d08786f53a5cccbcc038431df4
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
AIMS A population pharmacokinetic (PK) analysis was performed to: (1) characterise the PK of unbound and total mycophenolic acid (MPA) and its 7-O-mycophenolic acid glucuronide (MPAG) metabolite, and (2) identify the clinically significant covariates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa322afb88c3ee02ce5538bcc984952f
http://arxiv.org/abs/1912.13417
http://arxiv.org/abs/1912.13417